Rhythm Pharmaceuticals, Inc.
RYTM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001649904
In the last 90 days, Rhythm Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 305 institutions reported holding it in 13F filings for Q2 2026, worth $8.55B in total; Duquesne Family Office is the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Rhythm Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 90 | 2 | 101 | +13 |
| Shares | 45.9M | 274 | 59.5M | +13.5M (+29.5%) |
| Value | $190.8M | $1.04K | $1.45B | +$1.25B (+657.6%) |
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (35)
Institutions that held Rhythm Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (22)
Institutions that held Rhythm Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Franklin Resources Inc | 1,779,465 | $7.38M |
| MPM Asset Management LLC | 909,258 | $3.77M |
| Millennium Management LLC | 489,121 | $2.03M |
| Jacobs Levy Equity Management, Inc | 378,714 | $1.57M |
| Deerfield Management Company, L.P. (Series C) | 291,005 | $1.21M |
| Ergoteles LLC | 212,800 | $883.0K |
| Caxton Associates LP | 151,213 | $628.0K |
| SG Americas Securities, LLC | 80,064 | $332.0K |
| Bell & Brown Wealth Advisors, LLC | 70,400 | $293.0K |
| Public Employees Retirement System of Ohio | 57,218 | $237.0K |
| Chicago Partners Investment Group LLC | 12,821 | $162.0K |
| Cornercap Investment Counsel Inc | 36,663 | $152.0K |
| Bailard, Inc. | 29,500 | $122.0K |
| Qube Research & Technologies Ltd | 28,794 | $119.0K |
| ACT Capital Management, LLC | 27,500 | $114.0K |
| Simplex Trading, LLC | 25,890 | $107.0K |
| Virtu Financial LLC | 22,666 | $94.0K |
| Laurion Capital Management LP | 16,322 | $68.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 11,225 | $47.0K |
| AQR Capital Management LLC | 10,295 | $43.0K |
| Aquatic Capital Management LLC | 2,300 | $10.0K |
| FourThought Financial, LLC | 1,776 | $7.00K |
Not filed for Q3 2022 yet (2)
Institutions that held Rhythm Pharmaceuticals, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Private Capital Group, LLC | 264 | $1.00K |
| Exane Derivatives | 10 | $41 |